How is an MT-ND6 gene mutation inherited within a family?

Because MT-ND6 is located on mitochondrial DNA (mtDNA), it is inherited exclusively through the maternal lineage. A female carrying the variant will transmit it to all of her biological children, whereas an affected male cannot pass it to his offspring. However, not all individuals who inherit the mutation develop symptoms due to incomplete penetrance and variations in heteroplasmy (the proportion of mutant versus normal mtDNA).

When can an MT-ND6 mutation cause Leigh syndrome instead of vision loss alone?

When an MT-ND6 pathogenic variant is present at a very high mutant load (high heteroplasmy nearing 100 percent) or involves a severe loss-of-function change, baseline mitochondrial ATP generation falls below the threshold needed for brainstem and basal ganglia survival. This causes the severe psychomotor regression, respiratory failure, and bilateral symmetrical brain lesions typical of Leigh syndrome during infancy, rather than isolated optic nerve degeneration.

How does the MT-ND6 m.14484T>C mutation compare in visual prognosis to other LHON mutations?

The MT-ND6 m.14484T>C variant generally has the most favorable visual prognosis among the primary mutations causing Leber hereditary optic neuropathy. Approximately 35 to 50 percent of affected individuals experience partial, spontaneous visual recovery over time, characterized by clearing of central scotomas, especially if vision loss begins before the age of 20.

What environmental triggers should someone carrying an MT-ND6 variant strictly avoid?

Carriers must avoid all forms of tobacco smoke (including secondhand smoke) and excessive alcohol consumption, as these generate severe reactive oxygen species that overwhelm already vulnerable mitochondrial complex I function. Patients should also avoid mitochondrial-toxic drugs, such as certain aminoglycoside antibiotics, linezolid, and ethambutol, whenever clinical alternatives exist.

MT-ND6 gene

MT‑ND6 encodes the NADH dehydrogenase 6 protein, a core component of mitochondrial complex I, and pathogenic variants are associated with Leber hereditary optic neuropathy, Leigh syndrome, and mitochondrial complex I deficiency.

Overview

Normal Function

The MT‑ND6 gene provides instructions for making a protein called NADH dehydrogenase 6. This protein is part of a large enzyme complex known as complex I, which is active in mitochondria. Mitochondria are structures within cells that convert the energy from food into a form that cells can use. These cellular structures produce energy through a process called oxidative phosphorylation, which uses oxygen and simple sugars to create adenosine triphosphate (ATP), the cell’s main energy source.

Complex I is one of several enzyme complexes necessary for oxidative phosphorylation. Within mitochondria, these complexes are embedded in a tightly folded, specialized membrane called the inner mitochondrial membrane. During oxidative phosphorylation, mitochondrial enzyme complexes carry out chemical reactions that drive the production of ATP. Specifically, they create an unequal electrical charge on either side of the inner mitochondrial membrane through a step‑by‑step transfer of negatively charged particles called electrons. This difference in electrical charge provides the energy for ATP production.

Complex I is responsible for the first step in the electron transport process, the transfer of electrons from a molecule called NADH to another molecule called ubiquinone. Electrons are then passed from ubiquinone through several other enzyme complexes to provide energy for the generation of ATP.

Health Conditions Related to Genetic Changes

Leber hereditary optic neuropathy

Several variants (also called mutations) in the MT‑ND6 gene have been identified in people with Leber hereditary optic neuropathy. This condition is an inherited form of vision loss. Each of the MT‑ND6 gene variants changes a single protein building block (amino acid) in the NADH dehydrogenase 6 protein. One common MT‑ND6 gene variant is responsible for about 14 percent of all cases of Leber hereditary optic neuropathy, and it is the most common cause of this disorder among people of French Canadian descent. This genetic change, written as T14484C or Met64Val, replaces the amino acid methionine with the amino acid valine at protein position 64. The T14484C variant is associated with a good long‑term prognosis; affected people with this genetic change have a 37 percent to 65 percent chance of some visual recovery.

Researchers are investigating how variants in the MT‑ND6 gene lead to Leber hereditary optic neuropathy. These genetic changes appear to prevent complex I from interacting normally with ubiquinone, which may affect the generation of ATP.

Variants in another gene called MT‑ND4 may also increase the production within mitochondria of potentially harmful molecules called reactive oxygen species. It remains unclear, however, why the effects of these variants are often limited to the nerve that relays visual information from the eye to the brain (the optic nerve). Additional genetic and environmental factors probably contribute to the vision loss and other medical problems associated with Leber hereditary optic neuropathy.

Leigh syndrome

A variant in the MT‑ND6 gene also has been identified in a small number of people with Leigh syndrome, a progressive brain disorder that typically appears in infancy or early childhood. Affected children may experience vomiting, seizures, delayed development, muscle weakness, and problems with movement. Heart disease, kidney problems, and difficulty breathing can also occur in people with Leigh syndrome.

The MT‑ND6 gene variant that can cause Leigh syndrome, written as G14459A or Ala72Val, replaces the amino acid alanine with the amino acid valine at protein position 72. This genetic change also has been found in people with Leber hereditary optic neuropathy and a movement disorder called dystonia, which involves involuntary muscle contractions, tremors, and other uncontrolled movements. This variant appears to disrupt the normal assembly or activity of complex I in mitochondria. It is not known, however, how this MT‑ND6 gene alteration is related to the specific features of Leigh syndrome, Leber hereditary optic neuropathy, or dystonia. It also remains unclear why a single variant can cause such varied signs and symptoms in different people.

Mitochondrial complex I deficiency

MedlinePlus Genetics provides information about mitochondrial complex I deficiency.

Other Names for This Gene

mitochondrially encoded NADH dehydrogenase 6
MTND6
NADH dehydrogenase 6
NADH dehydrogenase subunit 6
NADH‑ubiquinone oxidoreductase chain 6
NADH‑ubiquinone oxidoreductase, subunit ND6
ND6
NU6M_HUMAN

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Tests of MT‑ND6

Scientific Articles on PubMed

PubMed

Catalog of Genes and Diseases from OMIM

COMPLEX I, SUBUNIT ND6; MTND6
LEIGH SYNDROME, NUCLEAR; NULS

Gene and Variant Databases

NCBI Gene
ClinVar

References

Baracca A, Solaini G, Sgarbi G, Lenaz G, Baruzzi A, Schapira AH, Martinuzzi A, Carelli V. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch Neurol. 2005 May;62(5):730-6. doi: 10.1001/archneur.62.5.730.
Carelli V, Ghelli A, Bucchi L, Montagna P, De Negri A, Leuzzi V, Carducci C, Lenaz G, Lugaresi E, Degli Esposti M. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann Neurol. 1999 Mar;45(3):320-8.
Chinnery PF, Andrews RM, Turnbull DM, Howell NN. Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? Am J Med Genet. 2001 Jan 22;98(3):235-43. doi: 10.1002/1096-8628(20010122)98:33.0.co;2‑o.
Fauser S, Leo‑Kottler B, Besch D, Luberichs J. Confirmation of the 14568 mutation in the mitochondrial ND6 gene as causative in Leber's hereditary optic neuropathy. Ophthalmic Genet. 2002 Sep;23(3):191-7. doi: 10.1076/opge.23.3.191.7881.
Gropman A, Chen TJ, Perng CL, Krasnewich D, Chernoff E, Tifft C, Wong LJ. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A. 2004 Feb 1;124A(4):377-82. doi: 10.1002/ajmg.a.20456.
Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics. 2001 Jul;3(3):119-25. doi: 10.1007/s100480100115.
Kirby DM, Kahler SG, Freckmann ML, Reddihough D, Thorburn DR. Leigh disease caused by the mitochondrial DNA G14459A mutation in unrelated families. Ann Neurol. 2000 Jul;48(1):102-4.
Lenaz G, Baracca A, Carelli V, D'Aurelio M, Sgarbi G, Solaini G. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim Biophys Acta. 2004 Jul 23;1658(1‑2):89-94. doi: 10.1016/j.bbabio.2004.03.013.
Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation in mitochondrial complex I genes: mutation or polymorphism? J Med Genet. 2006 Feb;43(2):175-9. doi: 10.1136/jmg.2005.032474.
Tarnopolsky MA, Baker SK, Myint T, Maxner CE, Robitaille J, Robinson BH. Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation. Am J Med Genet A. 2004 Feb 1;124A(4):372-6. doi: 10.1002/ajmg.a.20449.
Valentino ML, Avoni P, Barboni P, Pallotti F, Rengo C, Torroni A, Bellan M, Baruzzi A, Carelli V. Mitochondrial DNA nucleotide changes C14482G and C14482A in the ND6 gene are pathogenic for Leber's hereditary optic neuropathy. Ann Neurol. 2002 Jun;51(6):774-8. doi: 10.1002/ana.10193.